+

WO1999063979A3 - Inhibition de l'activite de δ-9-desaturase au moyen de saponines - Google Patents

Inhibition de l'activite de δ-9-desaturase au moyen de saponines Download PDF

Info

Publication number
WO1999063979A3
WO1999063979A3 PCT/US1999/012304 US9912304W WO9963979A3 WO 1999063979 A3 WO1999063979 A3 WO 1999063979A3 US 9912304 W US9912304 W US 9912304W WO 9963979 A3 WO9963979 A3 WO 9963979A3
Authority
WO
WIPO (PCT)
Prior art keywords
saponins
inhibition
desaturase activity
methods
saponin
Prior art date
Application number
PCT/US1999/012304
Other languages
English (en)
Other versions
WO1999063979A2 (fr
Inventor
Sambasiva R Chavali
R Armour Forse
Original Assignee
Sambasiva R Chavali
R Armour Forse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sambasiva R Chavali, R Armour Forse filed Critical Sambasiva R Chavali
Priority to AU44149/99A priority Critical patent/AU4414999A/en
Priority to EP99927180A priority patent/EP1100511A2/fr
Publication of WO1999063979A2 publication Critical patent/WO1999063979A2/fr
Publication of WO1999063979A3 publication Critical patent/WO1999063979A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur des compositions comprenant une saponine ou un métabolite de saponine telles que des compléments alimentaires et des solutions nutritionnelles, ces compositions étant destinées à être utilisées comme inhibiteurs de l'enzyme Δ-9-désaturase. L'invention porte également sur des procédés d'inhibition de l'activité de l'enzyme Δ-9- désaturase, et sur des procédés de traitement de l'obésité, des diabètes et de l'athérosclérose.
PCT/US1999/012304 1998-06-08 1999-06-03 Inhibition de l'activite de δ-9-desaturase au moyen de saponines WO1999063979A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU44149/99A AU4414999A (en) 1998-06-08 1999-06-03 Inhibition of delta-9-desaturase activity by saponins
EP99927180A EP1100511A2 (fr) 1998-06-08 1999-06-03 Inhibition de l'activite de delta-9-desaturase au moyen de saponines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9311398A 1998-06-08 1998-06-08
US09/093,113 1998-06-08

Publications (2)

Publication Number Publication Date
WO1999063979A2 WO1999063979A2 (fr) 1999-12-16
WO1999063979A3 true WO1999063979A3 (fr) 2000-03-16

Family

ID=22237219

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/012304 WO1999063979A2 (fr) 1998-06-08 1999-06-03 Inhibition de l'activite de δ-9-desaturase au moyen de saponines

Country Status (3)

Country Link
EP (1) EP1100511A2 (fr)
AU (1) AU4414999A (fr)
WO (1) WO1999063979A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60142692D1 (de) 2000-02-24 2010-09-09 Xenon Genetics Inc Stearoyl-coa-desaturase zur identifizierung von triglyceridreduktionstherapeutika
DE60134995D1 (de) 2000-09-26 2008-09-04 Xenon Pharmaceuticals Inc Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
US20050043256A1 (en) 2001-07-30 2005-02-24 Isis Pharmaceuticals, Inc. Antisense modulation of stearoyl-CoA desaturase expression
US7132529B2 (en) 2001-07-30 2006-11-07 Isis Pharmaceuticals, Inc. Antisense modulation of stearoyl-CoA desaturase expression
JP4494198B2 (ja) * 2004-12-28 2010-06-30 クラシエホームプロダクツ株式会社 膵リパーゼ阻害剤、脂肪分解抑制剤、及び、脂肪肝予防剤又は治療剤
GT200600046A (es) * 2005-02-09 2006-09-25 Terapia de combinacion
MA46589A (fr) 2016-10-24 2019-08-28 Yumanity Therapeutics Inc Composés et utilisations de ces derniers
JP2020514293A (ja) 2017-01-06 2020-05-21 ユマニティ セラピューティクス，インコーポレーテッド 神経障害を治療する方法
WO2019084157A1 (fr) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Composés et utilisations de ces composés
CA3094527A1 (fr) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Composes et leurs utilisations
WO2020154571A1 (fr) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Composés et leurs utilisations
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54135210A (en) * 1978-04-07 1979-10-20 Shigeru Yuuchi Tumor treating agent
JPS55122724A (en) * 1979-03-13 1980-09-20 Res Inst For Prod Dev Antidiabetic agent
JPS60172926A (ja) * 1984-02-15 1985-09-06 Osaka Chem Lab 健康食品
JPS6124597A (ja) * 1984-07-12 1986-02-03 Yamanouchi Pharmaceut Co Ltd 抗糖尿病剤
JPH07267977A (ja) * 1994-03-31 1995-10-17 I T Bi S:Kk オタネ人参の果実エキスよりなる配糖体及びその製造方法並びにこれを用いた健康食品とその製造方法
JPH0859496A (ja) * 1994-08-16 1996-03-05 Minoru Morimoto 高麗人参培地に茸種菌を植菌培養してその培地と茸菌糸体からエキスを抽出する製法
WO1997018824A1 (fr) * 1995-11-22 1997-05-29 Cheil Je Dang Co. Composition vasodilatatrice

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54135210A (en) * 1978-04-07 1979-10-20 Shigeru Yuuchi Tumor treating agent
JPS55122724A (en) * 1979-03-13 1980-09-20 Res Inst For Prod Dev Antidiabetic agent
JPS60172926A (ja) * 1984-02-15 1985-09-06 Osaka Chem Lab 健康食品
JPS6124597A (ja) * 1984-07-12 1986-02-03 Yamanouchi Pharmaceut Co Ltd 抗糖尿病剤
JPH07267977A (ja) * 1994-03-31 1995-10-17 I T Bi S:Kk オタネ人参の果実エキスよりなる配糖体及びその製造方法並びにこれを用いた健康食品とその製造方法
JPH0859496A (ja) * 1994-08-16 1996-03-05 Minoru Morimoto 高麗人参培地に茸種菌を植菌培養してその培地と茸菌糸体からエキスを抽出する製法
WO1997018824A1 (fr) * 1995-11-22 1997-05-29 Cheil Je Dang Co. Composition vasodilatatrice

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
CHAVALI ET AL.: "Decreased production of Interleukin-1-beta, Prostaglandin-E2 and Thromboxane B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Qil-A saponin", INT. ARCH. ALLERGY IMMUNOL., vol. 114, no. 2, October 1997 (1997-10-01), pages 153 - 160, XP000853999 *
CHAVALI ET AL.: "Dietary alpha-linolenic acid increases TNF-alpha and decreases IL-6, Il-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega-6 and omega-3 fatty acids in mice", PROSTAGLANDINS LEUKOTR. ESSENTIAL FATTY ACIDS, vol. 58, no. 3, March 1998 (1998-03-01), pages 185 - 191, XP000856146 *
DATABASE WPI Week 197948, Derwent World Patents Index; AN 1979-86683b, XP002127157 *
DATABASE WPI Week 198045, Derwent World Patents Index; AN 1980-79615c, XP002127156 *
DATABASE WPI Week 198542, Derwent World Patents Index; AN 1985-259594, XP002127155 *
DATABASE WPI Week 199550, Derwent World Patents Index; AN 1995-390277, XP002127154 *
DATABASE WPI Week 199619, Derwent World Patents Index; AN 1996-184705, XP002127158 *
NAKABAYASHI A. ET AL.: "Alpha-tocopherol enhances the hypocholesterolemic action od sesamin in rats", INT. J. VITAMIN NUTR. RES., vol. 65, no. 3, 1995, pages 162 - 168, XP000856322 *
NORMAN ET AL.: "Licorice-derived compounds inhibit linoleic aicd (C:18:2 omega-6) desaturation in soybean chloroplasts", FEBS LETT., vol. 368, no. 1, 10 July 1995 (1995-07-10), pages 135 - 138, XP002127153 *
PATENT ABSTRACTS OF JAPAN vol. 0, no. 0 *
SHIMIZU ET AL.: "Sesamin is a potent and specific inhibitor of delta-5 desaturase in polyunsaturated fatty acid biosynthesis", LIPIDS, vol. 26, no. 7, 1991, pages 512 - 516, XP002910626 *

Also Published As

Publication number Publication date
EP1100511A2 (fr) 2001-05-23
AU4414999A (en) 1999-12-30
WO1999063979A2 (fr) 1999-12-16

Similar Documents

Publication Publication Date Title
ZA977102B (en) Compositions of plant carbohydrates as dietary supplements.
WO1999043651A3 (fr) Inhibiteurs d'enzymes phospholipases
WO1999063979A3 (fr) Inhibition de l'activite de δ-9-desaturase au moyen de saponines
EP0858799A3 (fr) Compositions comprenant des hydroxyacides ou des retinoides
AU4178000A (en) Inline hemostatis valve
WO1999066913A3 (fr) Composition utilisee dans la prevention et/ou le traitement de l'osteoporose et modifications induites par le syndrome de la menopause
WO2001062266A3 (fr) Inhibition de la degenerescence des cellules beta
AU2037700A (en) Plant vitamin e biosynthetic enzymes
WO2000071703A3 (fr) Inhibition d'histone deacetylase
HK1041407A1 (en) Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors.
ZA991975B (en) Enzyme inhibitors.
EP1283058A4 (fr) Agents permettant de prevenir ou d'ameliorer l'insulino-resistance et/ou l'obesite
WO2001091764A3 (fr) Extraction de principes actifs pharmaceutiques de spermatophytes, produits ainsi obtenus, et utilisation medicale comme modulateurs immunitaires
AU2001284527A1 (en) Wild apple polyphenol and process for producing the same
AU5078396A (en) Alpha-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
AU2003259112A8 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
CA2371896A1 (fr) Procede permettant d'augmenter la teneur en flavonoides et en composants phenoliques dans des plantes
AU5066099A (en) Method for processing soybean by using enzyme, processed soybean thus obtained and foods containing the thus processed soybean
AU1278100A (en) 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses
AU8853998A (en) Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
AU2003267731A1 (en) Argyrolobium roseum plant extracts for treating diabetes
WO1998028299A3 (fr) Imidazopyridazines
EP1213027A3 (fr) Agent pour la protection ou l'amélioration de la fonction hépatique
AU3592999A (en) Preparation based on the artichoke plant, especially for use as a medicament or food supplement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1999927180

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999927180

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999927180

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载